2024 Annual Meeting | C134 - Coding Update: Turning Coding into Dollars and Sense

Date Tuesday 04/16/24

Time 03:30 PM - 05:30 PM MDT Add To Calendar

Location Colorado Convention Center | 601

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Brian T. Cabaniss, MD

Topic(s) Practice, Policy, and Ethics

Learning Objectives Participants should become familiar with high-yield recent topics in coding to help them get reimbursed for the work they are doing, including an overview and key concepts from the 2021 Outpatient E/M changes, the 2023 Inpatient E/M changes, Critical Care, non-face-to-face codes, and important new codes and rules for 2024 (changes to split/shared billing and G2211 add-on code).

CME Available 2.00 CME credits

Core Competencies Systems-based Practice

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Business Administrator

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:35 PM MDT	Speaker	Introduction Brian T. Cabaniss, MD
03:35 PM - 03:55 PM MDT	Speaker	Outpatient E/M, G2211 Brian T. Cabaniss, MD
03:55 PM - 04:25 PM MDT	Speaker	Inpatient E/M, Critical Care E/M, Split-shared Billing Sayona John, MD, FAAN
04:25 PM - 04:55 PM MDT	Speaker	Non-face-to-face Codes, Miscellaneous Gabriela De Bruin, MD
04:55 PM - 05:30 PM MDT	Q&A	Questions & Answers Brian T. Cabaniss, MD, Sayona John, MD, FAAN, Gabriela De Bruin, MD

Faculty Disclosures
Brian T. Cabaniss, MD	The institution of Dr. Cabaniss has received research support from Medtronic. The institution of Dr. Cabaniss has received research support from Takeda Pharmaceuticals.
Sayona John, MD, FAAN	Dr. John has nothing to disclose.
Gabriela De Bruin, MD	An immediate family member of Dr. De Bruin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. De Bruin has stock in Neuroquestions LLC. An immediate family member of Dr. De Bruin has stock in Neuroquestions LLC.